Genomic characterization of ependymomas reveals 6q loss as the most common aberration - Test2 - elhamkhani - TriplyDB

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

http://www.wikidata.org/entity/Q33881660

about

The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.Recent Advances in Intradural Spinal Tumors.

P2860

Q26766642-37701AE6-1774-488A-8746-434D981E9B42 Q36082481-4AE62056-CDD3-401D-9C31-D318BC2C30C8 Q37529593-0AEF926A-94BB-430C-A1D8-3A882F4883BC Q50027408-6DD70E49-98B5-4CAA-999B-0CA8E63CFFBF

P2860

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

http://www.wikidata.org/entity/Q33881660

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

@ast

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

@en

type

label

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

@ast

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

@en

prefLabel

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

@ast

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

@en

P1433

Q33881660-C435A374-508E-4142-B150-9349AA62D24C

P1476

Q33881660-199212AA-0CB7-4BB7-A552-1AF4A0817DDB

P2093

Q33881660-2347D4DB-962D-4646-93DD-18AE2D2AB849

Q33881660-5F81CF4D-A6B9-4098-9747-570EFB1F8BEA

Q33881660-682AB279-71C8-4A19-87F8-0BE73BE7C751

Q33881660-B5CB3F45-6B5B-43FB-A66E-8DAA0AB20FC9

Q33881660-D786EB6C-BFBA-4102-9B1A-A132738B39F9

P2860

Q33881660-091E5DB5-2EAF-4C59-AADB-FD3F8E2466CB

Q33881660-1832A848-E282-42AA-8DF0-72EA7E1F1920

Q33881660-2498373C-AE86-43CC-BA1A-6C3FE3AC75E7

Q33881660-27A9C1C5-448F-4343-A0B8-CA6712F23499

Q33881660-33A01411-12EA-48AB-94C7-EB8B4550AB0C

Q33881660-38677198-A5D1-4D20-964B-094C14C452C8

Q33881660-3B3FFD9D-B6A5-4B2B-8AB2-7BDAFBCCFC67

Q33881660-3E24166F-B34C-487A-AA97-6DF29CC9FD2C

Q33881660-5F17E123-E816-424A-8398-0EB91B5958B6

Q33881660-5FD9B9EE-7764-4DC7-BB9B-66D37F8E402C

P304

Q33881660-288ABFA9-03AC-4918-9D63-D7CC349DB723

P31

Q33881660-2C018A01-AB8A-41A0-9394-E364E46B92ED

P356

Q33881660-22BEB21A-FFF1-47B9-BE92-59AF7BD244C4

P433

Q33881660-2CB56FE5-B391-42FB-B496-23FE5F3703CB

P478

Q33881660-1C3CFDB7-16F8-4DC3-BE89-C5946C0092BE

P50

Q33881660-23A2486C-0C8C-4081-B270-8BC2FF0FA569

Q33881660-B68B2F7D-9883-4777-9505-3E60C5FB7554

Q33881660-BF2E7DBB-0C08-4C8A-930C-7DDA304EA7F7

P577

Q33881660-D1BF36C6-1C81-4DEC-AE2D-EF4A06D5B71E

P5875

Q33881660-E55A755B-B9DF-463C-8C0C-C27139C695D0

P698

Q33881660-BFB1313F-3E5F-41D8-AE74-D23A80DABEEA

P932

Q33881660-0363F6FE-4578-4894-A4C1-04A36F09443A

P356

P1433

Oncology Reports

P1476

Genomic characterization of ependymomas reveals 6q loss as the most common aberration

@en

P2093

David Scheie

http://www.w3.org/2001/XMLSchema#string

Francesca Micci

http://www.w3.org/2001/XMLSchema#string

Ludmila Gorunova

http://www.w3.org/2001/XMLSchema#string

Petter Brandal

http://www.w3.org/2001/XMLSchema#string

Thale Kristin Olsen

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer

Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3

SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994

Karyotype studies in 18 ependymomas with literature review of 107 cases.

Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.

Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.

Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.

P304

483-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2014.3271

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Torstein R. Meling

Bernt Johan Due-Tønnessen

P577

2014-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263294372

http://www.w3.org/2001/XMLSchema#string

P698

24939246

http://www.w3.org/2001/XMLSchema#string

P932

4091878

http://www.w3.org/2001/XMLSchema#string